Literature DB >> 20221872

Temporal and tissue-specific patterns of Pon3 expression in mouse: in situ hybridization analysis.

Diana M Shih1, Yu-Rong Xia, Janet M Yu, Aldons J Lusis.   

Abstract

PON3 is a member of the paraoxonase gene family that includes PON1 and PON2. For example, PON3 and PON1 share approximately 60% identity at the amino acid level. Recent studies have demonstrated that PON3 is present in human and rabbit HDL but not in mouse HDL. Mouse PON3 appears to be cell-associated and is expressed in a wide range of tissues such as liver, adipose, macrophage, and the artery wall. In vitro studies have shown that PON3 can prevent LDL oxidation and destroy bacterial quorum-sensing molecules. Previous studies also showed that human PON3 transgenic mice were protected from obesity and atherosclerosis in both the C57BL/6 J wild-type and LDLR knockout genetic background. Administration of adenovirus expressing the human PON3 gene into apoE -/- mice also decreased atherosclerotic lesion formation. In order to further understand the functions of PON3 in physiology and disease, we performed in situ hybridization analysis to examine Pon3 gene expression patterns in newborn and adult mice, in various tissues, including atherosclerotic lesions of apoE -/- mice. Our results show relatively high levels of Pon3 mRNA labeling in the adrenal gland, submaxillary gland, lung, liver, adipose, pancreas, large intestine, and other tissues of newborn mice. In the adult mouse, Pon3 mRNA levels were much lower in the corresponding tissues as mentioned above for the newborn mouse. Sections of the aortic root from the hearts of both wild-type and apoE -/- mice displayed moderate levels of Pon3 mRNA labeling. Pon3 mRNA was also detected in the atherosclerotic lesion areas at the aortic root of apoE -/- hearts. Our data revealed that mouse Pon3 is expressed in a wide range of tissues, and that its expression is temporally controlled.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221872      PMCID: PMC3018859          DOI: 10.1007/978-1-60761-350-3_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Quorum quenching enzyme activity is widely conserved in the sera of mammalian species.

Authors:  Fan Yang; Lian-Hui Wang; Jing Wang; Yi-Hu Dong; Jiang Yong Hu; Lian-Hui Zhang
Journal:  FEBS Lett       Date:  2005-07-04       Impact factor: 4.124

2.  Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.

Authors:  S T Reddy; D J Wadleigh; V Grijalva; C Ng; S Hama; A Gangopadhyay; D M Shih; A J Lusis; M Navab; A M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

3.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.

Authors:  Dragomir I Draganov; John F Teiber; Audrey Speelman; Yoichi Osawa; Roger Sunahara; Bert N La Du
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

4.  Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.

Authors:  C J Ng; D J Wadleigh; A Gangopadhyay; S Hama; V R Grijalva; M Navab; A M Fogelman; S T Reddy
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

Review 5.  Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms.

Authors:  M R Parsek; E P Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress.

Authors:  Mira Rosenblat; Dragomir Draganov; Catherine E Watson; Charles L Bisgaier; Bert N La Du; Michael Aviram
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

7.  Expression of human paraoxonase (PON1) during development.

Authors:  Toby B Cole; Rachel L Jampsa; Betsy J Walter; Tara L Arndt; Rebecca J Richter; Diana M Shih; Aaron Tward; Aldons J Lusis; Rhona M Jack; Lucio G Costa; Clement E Furlong
Journal:  Pharmacogenetics       Date:  2003-06

8.  Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence.

Authors:  C Hassett; R J Richter; R Humbert; C Chapline; J W Crabb; C J Omiecinski; C E Furlong
Journal:  Biochemistry       Date:  1991-10-22       Impact factor: 3.162

9.  Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues.

Authors:  Judit Marsillach; Bharti Mackness; Michael Mackness; Francesc Riu; Raul Beltrán; Jorge Joven; Jordi Camps
Journal:  Free Radic Biol Med       Date:  2008-04-11       Impact factor: 7.376

10.  Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase.

Authors:  M C Blatter; R W James; S Messmer; F Barja; D Pometta
Journal:  Eur J Biochem       Date:  1993-02-01
View more
  15 in total

1.  Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.

Authors:  Gerard Aragonès; Anabel García-Heredia; Marta Guardiola; Anna Rull; Raúl Beltrán-Debón; Judit Marsillach; Carlos Alonso-Villaverde; Bharti Mackness; Michael Mackness; Juan Pedro-Botet; Pedro Pardo-Reche; Jorge Joven; Jordi Camps
Journal:  J Lipid Res       Date:  2011-10-14       Impact factor: 5.922

Review 2.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

3.  Paraoxonase 3 functions as a chaperone to decrease functional expression of the epithelial sodium channel.

Authors:  Shujie Shi; Nicolas Montalbetti; Xueqi Wang; Brittney M Rush; Allison L Marciszyn; Catherine J Baty; Roderick J Tan; Marcelo D Carattino; Thomas R Kleyman
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

4.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

5.  Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.

Authors:  Yuepeng Jin; Qiang Li; Junjun Qiu; Xiufen Zhao; Chunxiao Zheng; Shixu Lv; Yongyu Bai; Yunfeng Shan; Le-Chi Ye
Journal:  Tumour Biol       Date:  2016-08-23

6.  Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role.

Authors:  Fernando Rodríguez-Sanabria; Anna Rull; Raúl Beltrán-Debón; Gerard Aragonès; Jordi Camps; Bharti Mackness; Michael Mackness; Jorge Joven
Journal:  J Mol Histol       Date:  2010-10-08       Impact factor: 2.611

7.  PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis.

Authors:  Diana M Shih; Janet M Yu; Laurent Vergnes; Nassim Dali-Youcef; Matthew D Champion; Asokan Devarajan; Peixiang Zhang; Lawrence W Castellani; David N Brindley; Carole Jamey; Johan Auwerx; Srinivasa T Reddy; David A Ford; Karen Reue; Aldons J Lusis
Journal:  FASEB J       Date:  2014-12-04       Impact factor: 5.191

8.  Developmental expression of paraoxonase 2.

Authors:  Jacqueline M Garrick; Khoi Dao; Rian de Laat; John Elsworth; Toby B Cole; Judit Marsillach; Clement E Furlong; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-04-07       Impact factor: 5.192

Review 9.  Inflammation, infection, cancer and all that…the role of paraoxonases.

Authors:  Asokan Devarajan; Diana Shih; Srinivasa T Reddy
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Expression of human paraoxonase 1 decreases superoxide levels and alters bacterial colonization in the gut of Drosophila melanogaster.

Authors:  Alejandro A Pezzulo; Emma E Hornick; Michael V Rector; Miriam Estin; Anna C Reisetter; Peter J Taft; Stephen C Butcher; A Brent Carter; J Robert Manak; David A Stoltz; Joseph Zabner
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.